Compare Wockhardt with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs FDC LTD. - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT FDC LTD. WOCKHARDT/
FDC LTD.
 
P/E (TTM) x -21.0 18.3 - View Chart
P/BV x 1.1 2.5 44.7% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 WOCKHARDT   FDC LTD.
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
FDC LTD.
Mar-18
WOCKHARDT/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs1,012319 317.2%   
Low Rs532164 324.1%   
Sales per share (Unadj.) Rs355.961.6 577.3%  
Earnings per share (Unadj.) Rs-60.39.9 -605.9%  
Cash flow per share (Unadj.) Rs-46.812.0 -390.9%  
Dividends per share (Unadj.) Rs0.010-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs257.873.2 352.3%  
Shares outstanding (eoy) m110.63174.40 63.4%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x2.23.9 55.4%   
Avg P/E ratio x-12.824.3 -52.7%  
P/CF ratio (eoy) x-16.520.2 -81.8%  
Price / Book Value ratio x3.03.3 90.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m85,37942,118 202.7%   
No. of employees `0006.35.5 113.1%   
Total wages/salary Rs m9,3712,167 432.5%   
Avg. sales/employee Rs Th6,295.01,943.7 323.9%   
Avg. wages/employee Rs Th1,498.3391.7 382.5%   
Avg. net profit/employee Rs Th-1,066.3313.7 -339.9%   
INCOME DATA
Net Sales Rs m39,36910,751 366.2%  
Other income Rs m1,202510 235.9%   
Total revenues Rs m40,57111,260 360.3%   
Gross profit Rs m182,267 0.8%  
Depreciation Rs m1,495351 425.5%   
Interest Rs m2,55514 18,249.3%   
Profit before tax Rs m-2,8302,411 -117.4%   
Minority Interest Rs m0-5 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m257671 38.3%   
Profit after tax Rs m-6,6691,735 -384.3%  
Gross profit margin %021.1 0.2%  
Effective tax rate %-9.127.8 -32.6%   
Net profit margin %-16.916.1 -105.0%  
BALANCE SHEET DATA
Current assets Rs m33,7967,213 468.6%   
Current liabilities Rs m26,9172,104 1,279.5%   
Net working cap to sales %17.547.5 36.8%  
Current ratio x1.33.4 36.6%  
Inventory Days Days7954 145.6%  
Debtors Days Days8928 321.8%  
Net fixed assets Rs m39,6646,865 577.8%   
Share capital Rs m553175 315.8%   
"Free" reserves Rs m27,96812,586 222.2%   
Net worth Rs m28,52212,761 223.5%   
Long term debt Rs m21,7316 362,185.0%   
Total assets Rs m81,62015,041 542.6%  
Interest coverage x-0.1173.2 -0.1%   
Debt to equity ratio x0.80 162,048.9%  
Sales to assets ratio x0.50.7 67.5%   
Return on assets %-5.011.6 -43.3%  
Return on equity %-23.413.6 -172.0%  
Return on capital %-7.719.0 -40.5%  
Exports to sales %012.3 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA1,327 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,8071,889 519.2%   
Fx outflow Rs m1,7890-   
Net fx Rs m8,0191,889 424.5%   
CASH FLOW
From Operations Rs m6841,498 45.7%  
From Investments Rs m6,302201 3,134.0%  
From Financial Activity Rs m-7,695-1,694 454.2%  
Net Cashflow Rs m-66410 -6,446.6%  

Share Holding

Indian Promoters % 74.5 68.9 108.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 4.7 48.9%  
FIIs % 7.7 7.5 102.7%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 19.0 81.1%  
Shareholders   67,757 23,730 285.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   GSK PHARMA  JUBILANT LIFE SCIENCES  DISHMAN PHARMA  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare WOCKHARDT With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

NARAYANA HRUDAYALAYA LTD Surges by 6%; BSE HEALTHCARE Index Down 0.6% (Market Updates)

Nov 11, 2019 | Updated on Nov 11, 2019

NARAYANA HRUDAYALAYA LTD share price has surged by 6% and its current market price is Rs 290. The BSE HEALTHCARE is down by 0.6%. The top gainers in the BSE HEALTHCARE Index are NARAYANA HRUDAYALAYA LTD (up 5.5%) and FDC LTD. (up 5.8%). The top losers are SUVEN LIFESCIENCES and JUBILANT LIFE SCIENCES .

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Generate Alpha over the Next Decade(Profit Hunter)

Oct 29, 2019

Here's your chance benefit from a safe approach to making money in stock markets .

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Nov 11, 2019 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WOCKHARDT 8-QTR ANALYSIS

COMPARE WOCKHARDT WITH

MARKET STATS